• Home
  • Journals
    • AUJ
    • JEMDSA
    • JMLSTSA
    • JSAVA
    • PNT
    • SAGP
    • SAJAA
    • SAJGH
    • SAJGO
    • SAJS
    • SAOJ
    • SAPA
    • SAPJ
    • WHSA
  • News
  • Advertise
  • CPD
  • Contact Us
  • Home
  • Journals
    • AUJ
    • JEMDSA
    • JMLSTSA
    • JSAVA
    • PNT
    • SAGP
    • SAJAA
    • SAJGH
    • SAJGO
    • SAJS
    • SAOJ
    • SAPA
    • SAPJ
    • WHSA
  • News
  • Advertise
  • CPD
  • Contact Us
  • Home
  • Journals
    • AUJ
    • JEMDSA
    • JMLSTSA
    • JSAVA
    • PNT
    • SAGP
    • SAJAA
    • SAJGH
    • SAJGO
    • SAJS
    • SAOJ
    • SAPA
    • SAPJ
    • WHSA
  • News
  • Advertise
  • CPD
  • Contact Us
Rare Disease Day 2026 puts equity for patients in the spotlight

Rare Disease Day 2026 puts equity for patients in the spotlight

by Chandré Blignaut | Mar 1, 2026 | Featured, News

Rare Disease Day 2026 puts equity for patients in the spotlight Johannesburg, 25 February 2026: Rare diseases each affect relatively small numbers of people, but collectively they impact more than 300 million individuals worldwide across over 7,000 known conditions,...
Sanofi receives registration for Beyfortus® in South Africa to protect infants against RSV

Sanofi receives registration for Beyfortus® in South Africa to protect infants against RSV

by Chandré Blignaut | Jan 30, 2026 | Featured, News

Sanofi receives registration for Beyfortus® in South Africa to protect infants against RSV Johannesburg, 28 January 2026: Sanofi is pleased to share that the South African Health Products Regulatory Authority (SAHPRA) has granted registration for Beyfortus®...
Cipla partners with ImmunoACT to launch talicabtagene autoleucel, an anti-CD19 CAR-T cell therapy for blood cancers in Africa

Cipla partners with ImmunoACT to launch talicabtagene autoleucel, an anti-CD19 CAR-T cell therapy for blood cancers in Africa

by Chandré Blignaut | Jan 30, 2026 | Featured, News

Cipla partners with ImmunoACT to launch talicabtagene autoleucel, an anti-CD19 CAR-T cell therapy for blood cancers in Africa South Africa, January 20, 2026: Cipla Limited (BSE: 500087; NSE: CIPLA; and hereafter referred to as “Cipla”), through its subsidiary Medpro...
The mouth–body connection: Why diabetes and oral health go hand in hand

The mouth–body connection: Why diabetes and oral health go hand in hand

by Chandré Blignaut | Nov 15, 2025 | Featured, News

The mouth–body connection: Why diabetes and oral health go hand in hand Every November, National Diabetes Month invites South Africans to take a closer look at one of the country’s most urgent health concerns, and one that’s still growing rapidly. But beyond blood...

Aspen highlights the rising diabetes disease burden

by Chandré Blignaut | Nov 15, 2025 | Featured, News

Aspen highlights the rising diabetes disease burden Johannesburg – On World Diabetes Day, JSE-listed Aspen Pharmacare Holdings Limited (“Aspen”), a global multinational specialty pharmaceutical company, continues to highlight the alarming impact of South Africa’s...
Bonitas and partners drive family health access at Mpumalanga Family Health Day

Bonitas and partners drive family health access at Mpumalanga Family Health Day

by Chandré Blignaut | Nov 4, 2025 | Featured, News

Bonitas and partners drive family health access at Mpumalanga Family Health Day Access to healthcare is one of South Africa’s most pressing public health challenges, with many families still facing barriers such as long travel distances, overburdened clinics and...
« Older Entries
© 2024 Medpharm Publications